Midatech Pharma plc
NASDAQ: MTP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Stephen A. Stamp
- Employees
- 20
- Headquarters
- Cardiff, United Kingdom
- IPO year
- 2015
- Market cap
- $2.0M
- Website
- https://www.midatechpharma.com
Loading MTP…
Loading profile data…Frequently asked questions about MTP
What does Midatech Pharma plc (MTP) do?
Midatech Pharma plc is a pharmaceutical company focused on the research and development of drug delivery technologies and therapeutic solutions across the United Kingdom, Europe, and international markets. Its active pipeline includes MTX110, an investigational direct-delivery treatment for aggressive brain tumors such as diffuse intrinsic ponti...
Where does MTP trade?
Midatech Pharma plc (MTP) trades on the NASDAQ Capital Market.
What sector is MTP in?
Midatech Pharma plc (MTP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Midatech Pharma plc?
Stephen A. Stamp is the chief executive officer of Midatech Pharma plc (MTP).
Where is Midatech Pharma plc headquartered?
Midatech Pharma plc is headquartered in United Kingdom.
Does MTP pay a dividend?
Midatech Pharma plc (MTP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MTP go public?
Midatech Pharma plc (MTP) completed its initial public offering in 2015.